论文部分内容阅读
[目的]观察乳腺癌术后应用康艾注射液联合化疗的临床疗效。[方法]将60例乳腺癌术后患者随机分为治疗组和对照组各30例,治疗组应用康艾注射液联合化疗进行治疗,对照组仅给予化疗进行治疗。观测肝功能、肾功能、血糖、电解质。21d为1个周期,治疗2个周期后判定疗效。[结果]治疗组患者的改善率为90.00%,对照组患者的改善率为73.33%,治疗组显著优于对照组(P<0.05)。[结论]乳腺癌术后应用康艾注射液联合化疗进行治疗,疗效显著,明显减轻化疗药物对机体的副作用,增强机体的免疫功能,能有效提高患者的生活质量,且使用安全、方便。
[Objective] To observe the clinical effect of Kangai injection combined with chemotherapy after breast cancer surgery. [Method] Sixty cases of postoperative breast cancer patients were randomly divided into treatment group and control group, 30 cases each. The treatment group was treated with Kangai injection combined with chemotherapy, while the control group only with chemotherapy. Observed liver function, renal function, blood glucose, electrolytes. 21d for a period of treatment to determine the efficacy of 2 cycles. [Results] The improvement rate of the treatment group was 90.00%, while the improvement rate of the control group was 73.33%. The treatment group was significantly better than the control group (P <0.05). [Conclusion] Kangai injection combined with chemotherapy for postoperative breast cancer treatment has significant curative effect, significantly reduces the side effects of chemotherapy drugs on the body and enhances the immune function of the body, which can effectively improve the quality of life of patients and is safe and convenient to use.